Mineralocorticoid receptor antagonist (MRA) use in UK heart failure care: a national primary care cohort study.

Saved in:
Bibliographic Details
Title: Mineralocorticoid receptor antagonist (MRA) use in UK heart failure care: a national primary care cohort study.
Authors: Maclean R; Institute of Health Informatics, Faculty of Population Health Sciences, University College London, London, UK r.maclean@ucl.ac.uk.; University College London Hospitals NHS Foundation Trust, London, UK., Chen Y; Institute of Health Informatics, Faculty of Population Health Sciences, University College London, London, UK.; Clinical and Research Informatics Unit, University College London Hospitals Biomedical Research Centre, London, UK., Lumbers RT; Institute of Health Informatics, Faculty of Population Health Sciences, University College London, London, UK.; University College London Hospitals NHS Foundation Trust, London, UK., Shah AD; Institute of Health Informatics, Faculty of Population Health Sciences, University College London, London, UK.; University College London Hospitals NHS Foundation Trust, London, UK.
Source: Heart (British Cardiac Society) [Heart] 2025 Sep 25; Vol. 111 (20), pp. 976-983. Date of Electronic Publication: 2025 Sep 25.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 9602087 Publication Model: Electronic Cited Medium: Internet ISSN: 1468-201X (Electronic) Linking ISSN: 13556037 NLM ISO Abbreviation: Heart Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1468-201X
DOI:10.1136/heartjnl-2024-325132